PubMed Health⌕ Search

PubMed · 3694091

Evaluation of a Holter system to record ST-segment changes.

Abstract

This study was performed to establish the accuracy of the Avionics 445B recorder and Innovator 750 scanner for identifying ST-segment changes in patients undergoing treadmill exercise testing. A series of 143 patients underwent treadmill exercise testing with 12-lead ECG monitoring and 2-lead Holter monitoring. The mean age of the patients (134 men and 9 women) was 59.3 years (range, 27 to 77). The frequency range of the recorder was 0.08 to 30 Hz. A modified V2 and V5 bipolar lead system was used for the Holter recording. The Holter tape was then scanned using the Innovator 750 scanner. The technician adjusted the baseline-reference point and J-point and then did not interact further with the recording. Treadmill exercise testing was undertaken using a submaximal Bruce protocol with 12 standard ECG leads recorded. Forty-two patients had positive ST-segment changes recorded by both the 12-lead ECG and the Holter monitor. Ninety-two patients had no ST-segment changes recorded by either of the systems. With the 12-lead ECG recorded during the treadmill exercise test used as the standard, the sensitivity of the Holter system was 89%, specificity 96%, and positive predictive accuracy 91%. The Holter recorder and automated scanning system should reliably detect episodes of ST-segment change occurring during ambulatory ECG monitoring.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S C Hammill. 1987. Evaluation of a Holter system to record ST-segment changes.. https://pubmed.ncbi.nlm.nih.gov/3694091/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Update on PPAR agonists: the clinical significance of FIELD and PROACTIVE.

The peroxisome proliferator-activated receptor (PPAR) family of genes plays a major role in metabolic regulation. Unfortunately, the results of two recent, large event trials of PPAR agonists have been mixed. High rates of crossover to statin use confound the interpretation of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial, which found a less than expected reduction in coronary and stroke events with fenofibrate. Of concern, nonsignificant increases in coronary and sudden deaths, thrombotic events, and pancreatitis occurred in the fenofibrate group. The PROspective pioglitAzone Clinical Trial In macroVascular Events (PROACTIVE) also found a reduction in coronary and stroke events with pioglitazone compared with placebo in a population with diabetes and cardiovascular disease, but this benefit was counterbalanced by an increase in congestive heart failure as well as symptomatic edema. Further research is needed to determine the role of PPAR agonists in the prevention of cardiovascular disease.

Coronary Disease↗

Depressive symptoms and sex affect completion rates and clinical outcomes in cardiac rehabilitation.

Symptoms of depression are often seen in patients with coronary heart disease. Symptoms appear more commonly in women and are negatively associated with measures of cardiovascular health. Using multiple logistic regression analyses, the authors evaluated the independent effects of depression (as measured by the Beck Depression Inventory [BDI-II]) and sex on cardiac rehabilitation (CR) completion. In addition, in those who completed CR, the authors evaluated whether depressive symptoms and sex affected clinical outcomes. Women as well as participants with enrollment BDI-II scores > or =14 had significantly higher rates of CR noncompletion. Patients with BDI-II scores > or =14 who completed CR achieved significant improvements in lipid profile, body mass index, and exercise capacity regardless of sex. Women and individuals with BDI-II scores > or =14 are at risk for CR noncompletion and should be encouraged to complete CR, because cardiovascular benefits comparable to those seen in men and individuals with low BDI-II scores were achieved when these patients completed the CR program.

Coronary Disease↗